Ligand Pharmaceuticals (LGND) Other Gross PP&E Adjustments (2011 - 2026)
Ligand Pharmaceuticals recorded quarterly Other Gross PP&E Adjustments of -$6.8 million in Q1 2026, down 835.63% quarter-over-quarter from $929000.0 in Q4 2025, and down 754.25% year-over-year from $1.0 million in Q1 2025.
Ligand Pharmaceuticals' Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at -$6.8 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 754.25% year-over-year to -$6.8 million; the TTM figure through Mar 2026 stood at -$6.8 million (down 754.25% YoY), while the FY2025 annual figure was $929000.0, down 92.02% from the prior year.
- Other Gross PP&E Adjustments came in at -$6.8 million for Q1 2026 at Ligand Pharmaceuticals, down from $929000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $17.9 million in Q4 2022 to a low of -$24.7 million in Q2 2022.
- A 5-year average of -$4.5 million and a median of -$6.8 million in 2026 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments soared 86.73% in 2025 and sank 754.25% in 2026, its largest moves.
- Ligand Pharmaceuticals' Other Gross PP&E Adjustments stood at $17.9 million in 2022, then slipped by 23.06% to $13.8 million in 2023, then decreased by 15.72% to $11.6 million in 2024, then slumped by 92.02% to $929000.0 in 2025, then plunged by 835.63% to -$6.8 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$6.8 million, $929000.0, and -$7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | -6.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.83 Mn |
| Mar 31, 2026 | -6.83 Mn |
| Dec 31, 2025 | 929,000.00 |
| Dec 31, 2025 | 929,000.00 |
| Sep 30, 2025 | -7.61 Mn |
| Sep 30, 2025 | -7.61 Mn |
| Jun 30, 2025 | -7.99 Mn |
| Jun 30, 2025 | -7.99 Mn |
| Mar 31, 2025 | -800,000.00 |
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | 11.64 Mn |
| Dec 31, 2024 | 11.64 Mn |
| Sep 30, 2024 | -7.16 Mn |
| Sep 30, 2024 | -7.16 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | 13.81 Mn |
| Dec 31, 2023 | 13.81 Mn |
| Sep 30, 2023 | -6.24 Mn |
| Sep 30, 2023 | -6.24 Mn |
| Jun 30, 2023 | -11.39 Mn |
| Jun 30, 2023 | -11.39 Mn |
| Mar 31, 2023 | -3.94 Mn |
| Mar 31, 2023 | -3.94 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | -14.44 Mn |
| Sep 30, 2022 | -14.44 Mn |
| Jun 30, 2022 | -24.71 Mn |
| Jun 30, 2022 | -24.71 Mn |
| Mar 31, 2022 | -15.78 Mn |
| Mar 31, 2022 | -15.78 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Sep 30, 2021 | -16.80 Mn |
| Sep 30, 2021 | -16.80 Mn |
| Jun 30, 2021 | -6.50 Mn |
| Jun 30, 2021 | -6.50 Mn |
| Mar 31, 2021 | -17.95 Mn |
| Mar 31, 2021 | -17.95 Mn |
| Dec 31, 2020 | 11.74 Mn |
| Dec 31, 2020 | 11.74 Mn |
| Sep 30, 2020 | -4.27 Mn |
| Sep 30, 2020 | -4.27 Mn |
| Jun 30, 2020 | -9.69 Mn |
| Jun 30, 2020 | -9.69 Mn |
| Mar 31, 2020 | -9.63 Mn |
| Mar 31, 2020 | -9.63 Mn |
| Dec 31, 2019 | -1.45 Mn |
| Dec 31, 2019 | -1.45 Mn |
| Sep 30, 2019 | -10.28 Mn |
| Sep 30, 2019 | -10.28 Mn |
| Jun 30, 2019 | -10.96 Mn |
| Jun 30, 2019 | -10.96 Mn |
| Mar 31, 2019 | -4.88 Mn |
| Mar 31, 2019 | -4.88 Mn |
| Dec 31, 2018 | 6.60 Mn |
| Dec 31, 2018 | 6.60 Mn |
| Dec 31, 2017 | 5.64 Mn |
| Dec 31, 2017 | 5.64 Mn |
| Dec 31, 2016 | 2.56 Mn |
| Dec 31, 2016 | 2.56 Mn |
| Jun 30, 2016 | 2.68 Mn |
| Jun 30, 2016 | 2.68 Mn |
| Mar 31, 2016 | 3.39 Mn |
| Mar 31, 2016 | 3.39 Mn |
| Dec 31, 2015 | 2.43 Mn |
| Dec 31, 2015 | 2.43 Mn |
| Sep 30, 2015 | 3.09 Mn |
| Sep 30, 2015 | 3.09 Mn |
| Jun 30, 2015 | 3.09 Mn |
| Jun 30, 2015 | 3.09 Mn |
| Mar 31, 2015 | 3.08 Mn |
| Mar 31, 2015 | 3.08 Mn |
| Dec 31, 2014 | 2.67 Mn |
| Dec 31, 2014 | 2.67 Mn |
| Sep 30, 2014 | 3.41 Mn |
| Sep 30, 2014 | 3.41 Mn |
| Jun 30, 2014 | 3.41 Mn |
| Jun 30, 2014 | 3.41 Mn |
| Mar 31, 2014 | 4.63 Mn |
| Mar 31, 2014 | 4.63 Mn |
| Dec 31, 2013 | 4.04 Mn |
| Dec 31, 2013 | 4.04 Mn |
| Sep 30, 2013 | 5.78 Mn |
| Sep 30, 2013 | 5.78 Mn |
| Jun 30, 2013 | 5.83 Mn |
| Jun 30, 2013 | 5.83 Mn |
| Dec 31, 2012 | 5.47 Mn |
| Dec 31, 2012 | 5.47 Mn |
| Dec 31, 2011 | -355,000.00 |
| Dec 31, 2011 | -355,000.00 |